关注
Anakha J
Anakha J
在 niper.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Towards development of biobetter: L-asparaginase a case study
RK Tripathy, J Anakha, AH Pande
Biochimica et Biophysica Acta (BBA)-General Subjects 1868 (1), 130499, 2024
72024
Human arginase 1, a Jack of all trades?
J Anakha, PS Kawathe, S Datta, SS Jawalekar, UC Banerjee, AH Pande
3 Biotech 12 (10), 264, 2022
72022
Treating liver cancer through arginine depletion
YR Prasad, J Anakha, AH Pande
Drug Discovery Today 29 (4), 103940, 2024
62024
Recombinant human endostatin as a potential anti-angiogenic agent: therapeutic perspective and current status
J Anakha, P Dobariya, SS Sharma, AH Pande
Medical Oncology 41 (1), 24, 2023
32023
Human arginase I: a potential broad-spectrum anti-cancer agent
J Anakha, YR Prasad, N Sharma, AH Pande
3 Biotech 13 (5), 159, 2023
32023
Development and characterization of fused human arginase I for cancer therapy
SS Jawalekar, PS Kawathe, N Sharma, J Anakha, K Tikoo, AH Pande
Investigational New Drugs 41 (5), 652-663, 2023
22023
Broad-spectrum anti-cancer activity of fused human arginase variants
YR Prasad, J Anakha, SS Jawalekar, AH Pande
Investigational New Drugs, 1-7, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–7